HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Butein inhibits metastatic behavior in mouse melanoma cells through VEGF expression and translation-dependent signaling pathway regulation.

AbstractBACKGROUND:
Melanoma is an aggressive skin cancer and a predominant cause of skin cancer-related deaths. A previous study has demonstrated the ability of butein to inhibit tumor proliferation and invasion. However, the anti-metastatic mechanisms and in vivo effects of butein have not been fully elucidated.
METHODS:
MTT cell viability assays were used to evaluate the antitumor effects of butein in vitro. Cytotoxic effects of butein were measured by lactate dehydrogenase assay. Anti-migratory effects of butein were evaluated by two-dimensional scratch and transwell migration assays. Signaling transduction and VEGF-releasing assays were measured by Western blotting and ELISA. We also conducted an experimental analysis of the metastatic potential of tumor cells injected into the tail vein of C57BL/6 mice.
RESULTS:
We first demonstrated the effect of butein on cell viability at non-cytotoxic concentrations (1, 3, and 10 μM). In vitro, butein was found to inhibit the migration of B16F10 cells in a concentration-dependent manner using transwell and scratch assays. Butein had a dose-dependent effect on focal adhesion kinase, Akt, and ERK phosphorylation in B16F10 cells. Butein efficiently inhibited the mTOR/p70S6K translational inhibition machinery and decreased the production of VEGF in B16F10 cells. Furthermore, the in vivo antitumor effects of butein were demonstrated using a pulmonary metastasis model.
CONCLUSION:
The results of the present study indicate the potential utility of butein in the treatment of melanoma.
AuthorsYu-Wei Lai, Shih-Wei Wang, Chien-Hsin Chang, Shih-Chia Liu, Yu-Jen Chen, Chih-Wen Chi, Li-Pin Chiu, Shiou-Sheng Chen, Allen W Chiu, Ching-Hu Chung
JournalBMC complementary and alternative medicine (BMC Complement Altern Med) Vol. 15 Pg. 445 (Dec 22 2015) ISSN: 1472-6882 [Electronic] England
PMID26694191 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Retracted Publication)
Chemical References
  • Chalcones
  • Vascular Endothelial Growth Factor A
  • butein
Topics
  • Animals
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Chalcones (administration & dosage)
  • Humans
  • Male
  • Melanoma, Experimental (drug therapy, metabolism, pathology, physiopathology)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Metastasis
  • Signal Transduction (drug effects)
  • Skin Neoplasms (drug therapy, metabolism, pathology, physiopathology)
  • Vascular Endothelial Growth Factor A (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: